AF Clinical Trials in Hangzhou, Zhejiang
27 recruitingHangzhou, Zhejiang, China
Showing 1–20 of 27 trials
Recruiting
Phase 4
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease
Graft vs Host DiseaseChronic Graft vs. Host DiseaseCorticosteroid-refractory Chronic Graft vs. Host Disease
Novartis Pharmaceuticals50 enrolled22 locationsNCT06824103
Recruiting
Phase 1
A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Metastatic Hepatocellular CarcinomaLocal Advanced Hepatocellular CarcinomaAlpha-fetoprotein (AFP)-Producing Gastric Cancer+2 more
BeOne Medicines392 enrolled46 locationsNCT06427941
Recruiting
Not Applicable
Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial
Atrial Fibrillation (AF)Catheter AblationAtrial Functional Mitral Regurgitation
Beijing Anzhen Hospital146 enrolled17 locationsNCT06883864
Recruiting
Not Applicable
Discontinuation of Anticoagulation With Intensive Rhythm Monitoring in Post-ablation Patients With Atrial Fibrillation
Atrial Fibrillation (AF)
Beijing Anzhen Hospital4,100 enrolled22 locationsNCT06871228
Recruiting
Phase 3
Evaluation of Rovadicitinib Compared to the Protocol Selected by Researchers in Third Line and Subsequent Studies of Moderate to Severe Chronic Graft-versus-host Disease
Graft-Versus-Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.182 enrolled41 locationsNCT06682169
Recruiting
Phase 2
Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab
Safety
Second Affiliated Hospital, School of Medicine, Zhejiang University40 enrolled2 locationsNCT07253896
Recruiting
Phase 4
Study of Efficacy and Safety of Ruxolitinib in Patients With Grade II to IV Steroid-refractory Acute Graft vs. Host Disease
Steroid-refractory Acute Graft Versus Host Disease
Novartis Pharmaceuticals36 enrolled17 locationsNCT06462469
Recruiting
Phase 2
The Safety and Efficacy of Cetuximab Beta Plus Fruquintinib With or Without Immune Checkpoint Inhibitorrs in First-line Treatment of RAS/BRAF Wild Type Unresectable Metastatic Colorectal Cancer
Colorectal NeoplasmsBRAFCetuximab+2 more
Zhejiang University70 enrolled1 locationNCT07257653
Recruiting
Not Applicable
A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD
MAFLD
The Affiliated Hospital of Hangzhou Normal University2,000 enrolled1 locationNCT07233486
Recruiting
Not Applicable
Ruxolitinib Plus Etanercept vs Ruxolitinib for Steroid-Refractory Severe Acute GVHD
Graft vs Host Disease
First Affiliated Hospital of Zhejiang University122 enrolled1 locationNCT07184853
Recruiting
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Efficacy, SelfSafety IssuesThromboembolic Disease+2 more
First People's Hospital of Hangzhou400 enrolled1 locationNCT04861506
Recruiting
Phase 3
Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases
Acute Graft Versus Host Disease
Anhui Provincial Hospital198 enrolled6 locationsNCT06294691
Recruiting
Chinese Atrial Fibrillation Registry
Atrial Fibrillation (AF)
Beijing Anzhen Hospital100,000 enrolled2 locationsNCT06987825
Recruiting
Phase 2
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Chronic Graft Versus Host Disease
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.52 enrolled12 locationsNCT06300320
Recruiting
Study of Atrial Fibrillation Combined with Atrial Functional Mitral Regurgitation
Atrial Fibrillation (AF)Atrial Functional Mitral Regurgitation
Second Affiliated Hospital, School of Medicine, Zhejiang University500 enrolled1 locationNCT06630936
Recruiting
The Effect of Perioperative Factors on Postoperative Outcomes After Lung Transplantation
Postoperative Complications After Lung Transplantation
Second Affiliated Hospital, School of Medicine, Zhejiang University200 enrolled1 locationNCT06603350
Recruiting
Phase 2
Adebrelimab Combined With Chemotherapy and Concurrent SBRT for Neoadjuvant Treatment of Limited-stage Small Cell Lung Cancer
Efficacy and Safety of Neoadjuvant Immunotherapy for Small Cell Lung Cancer
Zhejiang Cancer Hospital20 enrolled1 locationNCT06562920
Recruiting
Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
Skin graftKidney Transplant Rejection
Second Affiliated Hospital, School of Medicine, Zhejiang University24 enrolled3 locationsNCT05600634
Recruiting
Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen
Breast CancerEfficacyLiposomal Doxorubicin+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University150 enrolled1 locationNCT05731258
Recruiting
Not Applicable
Chinese Longitudinal and Systematic Study of Bioplar Disorder
Major Depressive DisorderBipolar Disorder, MixedAffective; Disorder, Organic
First Affiliated Hospital of Zhejiang University10,000 enrolled1 locationNCT05480150